Decision Aid Summary

Title Starting Immune Tolerance Induction (to get rid of inhibitors): when and what dose.
Audience Persons with hemophilia A or B who have developed an inhibitor to factor concentrate. Clinician and patient versions.
Options included Delayed start of Immune Tolerance Induction (ITI)
Early start of ITI.
High dose ITI with Immunosuppresant.
High dose ITI.
Low dose ITI.
Year of last update or review 2013
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer Alfonso Iorio
Where was it developed? iorioa@mcmaster.ca
McMaster University and Université Laval
Canada
Health condition Hemophilia
Type of decision aid Treatment
Language English
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
6 out of 7 criteria to be defined as a patient decision aid
7 out of 8 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.